Loading...
Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder:A Systematic Review of Clinical Trials
OBJECTIVE: Desvenlafaxine is the third serotonin-norepinephrine reuptake inhibitor (SNRI) approved by the US Food and Drug Administration for major depressive disorder (MDD). This article summarizes data on the clinical pharmacology, efficacy, safety, and tolerability of desvenlafaxine (administered...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Physicians Postgraduate Press, Inc.
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947544/ https://ncbi.nlm.nih.gov/pubmed/20944767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.09r00845blu |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|